Manish S. Patankar

ORCID: 0000-0002-8205-6432 · 6 papers in corpus
2024
Cancer research communications ·doi:10.1158/2767-9764.crc-23-0327

The biomarker CA125, a peptide epitope located in several tandem repeats of the mucin MUC16, is the gold standard for monitoring regression and recurrence of high-grade serous ovarian cancer in response to therapy. However, the CA125 epitop…

article 2023
Reproduction (Cambridge, England) ·doi:10.1530/rep-22-0265

IN BRIEF: Developing novel therapies to cure and manage endometriosis is a major unmet need that will benefit over 180 million women worldwide. Results from the current study suggest that inhibitors of oxidative phosphorylation may serve as…

article 2021
·doi:10.1016/s0090-8258(21)01227-0
article 2017
·doi:10.1158/1557-3265.ovcasymp16-tmem-033

Abstract The goal of this research project is to investigate if Non-Human Primates (NHP) can serve as model for endometriosis-associated Type I ovarian cancer. Endometriosis is a spontaneously occurring condition in both women and rhesus ma…

2013
Cancer letters ·doi:10.1016/j.canlet.2013.06.026

The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor mediates many biological processes. Herein, we investigated if 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE, an endogenous AhR ligand) r…

2010
Journal of ovarian research ·doi:10.1186/1757-2215-3-8

Ovarian cancer is particularly insidious in nature. Its ability to go undetected until late stages coupled with its non-descript signs and symptoms make it the seventh leading cause of cancer related deaths in women. Additionally, the lack …